ABC Stock: AmerisourceBergen Corporation Stock Price, Analysis & Insights
Get live abc stock price $179.98, comprehensive AmerisourceBergen Corporation stock analysis, charts, news, and expert forecast. Real-time abc stock data and investment insights.
Loading chart...
Company Overview
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Company Information
- CEO
- Steven H. Collis
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 46000
Contact Information
- Address
- 1 West First Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 21.9)
✓ Lower volatility stock (Beta: 0.56) may provide portfolio stability
Business Model & Strategy
AmerisourceBergen Corporation operates in the Medical - Distribution industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Steven H. Collis, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Distribution model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
AmerisourceBergen Corporation competes in the Medical - Distribution within the broader Healthcare. With 36.1 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, AmerisourceBergen Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating AmerisourceBergen Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for AmerisourceBergen Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for AmerisourceBergen Corporation
- ⚠Investors should consider how AmerisourceBergen Corporation fits within their overall portfolio allocation
Market Cap
36.15B
P/E Ratio
21.92
Beta
0.56
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 36.15B market capitalization
- Trading Volume: 806.05K shares traded today
- Price Range: 52-week range of $136.07 - $194.79
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for AmerisourceBergen Corporation
AmerisourceBergen Corporation (ABC) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 36.15B, the company represents a significant player in its market. The stock is currently trading at $179.98 with a negativedaily change of 0.23%.
The company's 46000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 21.92, beta of 0.56, and 52-week price range from $136.07 to $194.79when evaluating investment opportunities.
Why Invest in AmerisourceBergen Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Steven H. Collis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.